•  
  •  
  •  
  •  

2025-09-03 11:24:26

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes

Keywords Selected:  DivisLaboratories

Stock Report

  • Divis Laboratories Ltd posts consolidated Q1FY26 PAT of Rs. 545 crores
  • Divi's Laboratories inks long term manufacturing and supply agreement with global pharma company
  • Divi's Laboratories Limited recommends final dividend of Rs. 30
  • Divi's Laboratories Ltd reports higher consolidated PAT of Rs. 662 crores
  • Divi's Laboratories signs long-term manufacturing and supply agreement with global pharma company
  • Divis Laboratories Ltd posts consolidated PAT of Rs. 430 crores in Q1FY25
  • USFDA completes cGMP inspection of Divi's Laboratories Limited's Unit 2
  • Divi's Laboratories Ltd to expand capacity at an outlay of Rs. 650 to Rs. 700 crores
  • Divis Laboratories Ltd posts Rs. 348 crores consolidated net profit in Q2 FY2024
  • USFDA Delegation visits Divi's Laboratories Limited's Unit I at Choutuppal, Telangana, India
  • Divi's Laboratories Limited recommends dividend of Rs. 30
  • Divi's Laboratories Limited Q4FY23 consolidated PAT marginally up QoQ at Rs. 320.97 crores
  • Divi's Laboratories Selects Juniper Networks for Automated Network Infrastructure Across Massive Pharma Manufacturing Facilities
  • Divis Laboratories Ltd posts consolidated Q3FY23 PAT of Rs. 306.80 crores
  • Divis Laboratories Ltd Q2 FY2023 consolidated profit declines to Rs. 493.60 crores
  • Divis Laboratories Ltd reports consolidated PAT of Rs. 702.01 crores in Q1 FY2023
  • Divi's Laboratories Ltd recommends dividend of Rs. 30
  • Divi's Laboratories Q4FY22 consolidated PAT slips QoQ to Rs. 894.64 crores
  • Divis Laboratories Ltd consolidated Q3FY22 PAT zooms to Rs. 902.24 crores
  • Divis Laboratories Ltd consolidated Q2FY22 PAT up at Rs. 606.46 crore

Latest Post

  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024